Effects of cotinine on cigarette self-administration

被引:25
作者
Hatsukami, D
Lexau, B
Nelson, D
Pentel, PR
Sofuoglu, M
Goldman, A
机构
[1] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA
[2] Hennepin Cty Med Ctr, Dept Med, Minneapolis, MN 55415 USA
[3] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA
[4] Univ Minnesota, Dept Biostat, Minneapolis, MN 55455 USA
基金
美国国家卫生研究院;
关键词
cotinine; nicotine; smoking; self-administration;
D O I
10.1007/s002130050661
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Previous studies have shown that cotinine, a metabolite of nicotine, antagonizes some of the effects of nicotine. One study showed that cotinine eliminates the beneficial effects of the nicotine patch in reducing cigarette withdrawal symptoms. The purpose of this study was to examine the effects of various doses of cotinine on cigarette self-administration. Subjects were randomly assigned to one of three doses of cotinine fumarate (40, 80 and 160 mg) and placebo, each for a period of 10 days, in a randomized order. Outcome variables included measures of nicotine intake and subjective responses to smoked cigarettes. Results showed no differences in the number of cigarettes smoked, carbon monoxide levels, and weights of cigarette butts across the various doses of cotinine and placebo. However, higher nicotine serum levels were observed in the 160 mg cotinine fumarate condition compared to placebo and to 40mg cotinine fumarate. No systematic effects of cotinine on subjective responses to cigarettes were observed. Cotinine appears potentially to have a selective modulatory effect on nicotine withdrawal symptoms but not on cigarette smoking.
引用
收藏
页码:184 / 189
页数:6
相关论文
共 41 条
[21]   PHARMACODYNAMIC EFFECTS OF COTININE IN ABSTINENT CIGARETTE SMOKERS [J].
KEENAN, RM ;
HATSUKAMI, DK ;
PENTEL, PR ;
THOMPSON, TN ;
GRILLO, MA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (05) :581-590
[22]  
KIM KS, 1968, J PHARMACOL EXP THER, V161, P59
[23]  
KIM KS, 1964, FED PROC, V23, P330
[24]   Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible [J].
Malin, DH ;
Lake, JR ;
Payne, MC ;
Short, PE ;
Carter, VA ;
Cunningham, JS ;
Wilson, OB .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1996, 53 (01) :81-85
[25]   NICOTINE AND COTININE EFFECTS ON 3-ALPHA HYDROXYSTEROID DEHYDROGENASE IN CANINE PROSTATE [J].
MEIKLE, AW ;
LIU, XH ;
TAYLOR, GN ;
STRINGHAM, JD .
LIFE SCIENCES, 1988, 43 (23) :1845-1850
[26]   Diagnostic and Statistical Manual of Mental Disorders [J].
Mittal, Vijay A. ;
Walker, Elaine F. .
PSYCHIATRY RESEARCH, 2011, 189 (01) :158-159
[27]  
NATSUKAMI D, 1998, PSYCHOPHARMACOLOGY, V135, P141
[28]  
NEMETHCOSLETT R, 1986, PSYCHOPHARMACOLOGY, V88, P420
[29]   EFFECTS OF TRANSDERMAL CLONIDINE TREATMENT ON WITHDRAWAL SYMPTOMS ASSOCIATED WITH SMOKING CESSATION - A RANDOMIZED, CONTROLLED TRIAL [J].
ORNISH, SA ;
ZISOOK, S ;
MCADAMS, LA .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (09) :2027-2031
[30]  
RISNER ME, 1985, J PHARMACOL EXP THER, V234, P113